middle.news
How Will BCAL’s New Avantect Tests Transform Early Cancer Detection in Australia?
9:02am on Wednesday 21st of January, 2026 AEDT
•
Healthcare
Read Story
How Will BCAL’s New Avantect Tests Transform Early Cancer Detection in Australia?
9:02am on Wednesday 21st of January, 2026 AEDT
Key Points
Avantect pancreatic and ovarian cancer tests launched in Australia
National ethics approval for BREASTESTplus clinical data registry
$10 million convertible note facility established, $3 million drawn
Received approximately $2.5 million R&D tax refund
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bcal Diagnostics (ASX:BDX)
OPEN ARTICLE